Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)
Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)
Recruiting · NCT06231381 · Registry updated 2025-03-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP) | Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorder | Recruiting | Phase 2 | 2025-03-19 | NCT06231381 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Huaota Biopharmaceutical Co., Ltd. | 10 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking University People's Hospital (PKUPH) | Beijing | China | 1 |
| Shanghai Huaota Biopharmaceutical Co., Ltd | Shanghai | China | 1 |